Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus magnesium sulfate versus magnesium sulfate alone for prevention of ventricular arrhythmia after cardiac surgery
PACTR202502733720861Completed
- Sponsor
- Ain Shams University Hospitals
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of dexmedetomidine and magnesium sulfate in ventricular arrhythmia (VA) (2 arms), sponsored by Ain Shams University Hospitals. Primary endpoint: ventricular arrhythmia. Started Aug 2023; status: completed.
02
Drugs
dexmedetomidinemagnesium sulfate
03
Conditions
ventricular arrhythmia (VA)
Beyond the preview
Go deeper on PACTR202502733720861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202502733720861.